phenotype

NEURODEGENERATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEURODEGENERATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16617Connections

0Hypotheses

30Analyses

50Outgoing

50Incoming

0Experiments

20Debates

Summary

Neurodegeneration refers to the progressive structural and functional loss of neurons. It is the hallmark of diseases including Alzheimer's, Parkinson's, ALS, Huntington's, and frontotemporal dementia. Shared mechanisms across neurodegenerative diseases include proteostasis failure, mitochondrial dysfunction, oxidative stress, synaptic loss, and neuroinflammation. These convergent pathways are key targets for therapeutic intervention.

View on Wiki →

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

DNA Sensing Pathways in Neurodegeneration

mechanism · 3156 words

→

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| NEURON["NEURON"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| Neurodegeneration["Neurodegeneration"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| Alzheimer["Alzheimer"]
        TAU["TAU"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
        APOPTOSIS["APOPTOSIS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
        MS["MS"] -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
        FERROPTOSIS_2["FERROPTOSIS"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
    end
    subgraph Signaling["Signaling"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"regulates"| Als["Als"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| ALZHEIMER_S_DISEASE_1["ALZHEIMER'S DISEASE"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| P62["P62"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| FERROPTOSIS["FERROPTOSIS"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
        TAU_3["TAU"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
    end
    style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OLIGODENDROCYTE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style P62 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style FERROPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MS fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style FERROPTOSIS_2 fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU_3 fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (5913)

Target	Relation	Type	Str
AMYOTROPHIC LATERAL SCLEROSIS	activates	gene	1.00
NEURODEGENERATIVE DISORDERS	activates	gene	1.00
Immune Response	therapeutic_target	pathway	1.00
FERROPTOSIS	activates	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
P62	activates	gene	1.00
Proteasome	therapeutic_target	pathway	1.00
Ubiquitin-Proteasome	therapeutic_target	pathway	1.00
OLIGODENDROCYTE	associated_with	gene	1.00
Neurodegeneration	associated_with	disease	1.00
Neurogenesis	activates	pathway	1.00
Mitophagy	associated_with	pathway	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
Als	regulates	disease	1.00
Mitochondrial Function	therapeutic_target	pathway	1.00
Apoptosis	associated_with	pathway	1.00
Mitophagy	therapeutic_target	pathway	1.00
Immune Response	regulates	pathway	1.00
Mitophagy	activates	pathway	1.00
Apoptosis	therapeutic_target	pathway	1.00
Ferroptosis	activates	pathway	1.00
NEURON	associated_with	gene	1.00
Oxidative Stress	associated_with	pathway	1.00
Autophagy	inhibits	pathway	1.00
Oxidative Stress	contributes_to	pathway	1.00
Oxidative Stress	regulates	pathway	1.00
Mtor	associated_with	pathway	1.00
Mtor	activates	pathway	1.00
Blood-Brain Barrier	activates	pathway	1.00
Alzheimer	associated_with	disease	1.00
Alzheimer	associated_with	disease	1.00
Oxidative Stress	activates	pathway	1.00
Apoptosis	activates	pathway	1.00
Autophagy	associated_with	pathway	1.00
Apoptosis	regulates	pathway	1.00
Oxidative Stress	therapeutic_target	pathway	1.00
Autophagy	regulates	pathway	1.00
Blood-Brain Barrier	therapeutic_target	pathway	1.00
Nf-Κb	activates	pathway	1.00
Inflammation	associated_with	disease	1.00
Immune Response	activates	pathway	1.00
Synaptic Plasticity	activates	pathway	1.00
Dementia	associated_with	disease	1.00
Senescence	associated_with	disease	1.00
Autophagy	therapeutic_target	pathway	1.00
Complement	activates	pathway	1.00
Phagocytosis	activates	pathway	1.00
Autophagy	activates	pathway	1.00
Proteasome	activates	pathway	1.00
AUTOPHAGY	activates	gene	1.00

Incoming (10704)

Source	Relation	Type	Str
entities-ros	associated_with	wiki	0.00
entities-reactive-oxygen-species	associated_with	wiki	0.00
entities-hepcidin	associated_with	wiki	0.00
entities-atp7b-gene	associated_with	wiki	0.00
entities-histone-methylation	associated_with	wiki	0.00
DEMENTIA	causes	gene	1.00
PARKINSON	contributes_to	gene	1.00
DEMENTIA	activates	gene	1.00
INFLAMMATION	causes	gene	1.00
AUTOPHAGY	causes	gene	1.00
NEUROTOXICITY	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
PARKINSON'S DISEASE	contributes_to	gene	1.00
ASTROCYTES	activates	gene	1.00
NEURON	causes	gene	1.00
AGING	causes	gene	1.00
PARKINSON	causes	gene	1.00
LC3	activates	gene	1.00
MITOPHAGY	activates	gene	1.00
NEURODEGENERATION	causes	gene	1.00
ALZHEIMER	regulates	gene	1.00
AGING	associated_with	gene	1.00
AUTOPHAGY	inhibits	gene	1.00
NEURODEGENERATIVE DISEASES	contributes_to	gene	1.00
BRAIN INJURY	activates	gene	1.00
NEURODEGENERATION	interacts_with	gene	1.00
JUN	activates	gene	1.00
AUTOPHAGY	therapeutic_target	gene	1.00
NEURODEGENERATIVE DISEASES	associated_with	gene	1.00
PARKINSON'S DISEASE	causes	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
ALZHEIMER'S DISEASE	inhibits	gene	1.00
MITOCHONDRIAL DYSFUNCTION	associated_with	gene	1.00
ALPHA-SYNUCLEIN	activates	gene	1.00
BCL-2	activates	gene	1.00
PARKINSON'S DISEASE	activates	gene	1.00
TAU	inhibits	gene	1.00
APOE	regulates	protein	1.00
MITOCHONDRIAL DYSFUNCTION	activates	gene	1.00
ALS	therapeutic_target	gene	1.00
AMYLOID	regulates	gene	1.00
neuroinflammation	activates	process	1.00
tau pathology	activates	process	1.00
ApoE4	activates	protein	1.00
CASP3	associated_with	gene	1.00
autophagy	associated_with	process	1.00
MAPT	associated_with	gene	1.00
NEURODEGENERATION	inhibits	gene	1.00
CYTOKINES	activates	gene	1.00
MTOR	associated_with	protein	1.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (30)

Scientific analyses that reference this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

NEURODEGENERATION

Understanding Entity Pages

Summary

Wiki Pages (1)

DNA Sensing Pathways in Neurodegeneration

Pathway Diagram

Outgoing (5913)

Incoming (10704)

Targeting Hypotheses (0)

Mentioning Analyses (30)

Proteomics Differential Expression in AD CSF and Brain Tissue

How do different microglial subtypes (DAM vs inflammatory vs homeostatic) transi

Multi-modal Biomarker Panel Design for Early AD Detection

Do β-amyloid plaques and neurofibrillary tangles cause or result from cholinergi

test

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

What are the specific PTM changes in synaptic vesicle proteins during early AD p

What amyloid threshold level is required for optimal clinical benefit in early A

Why have anti-Aβ clinical trials failed despite the established role of Aβ in AD

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

How do sphingomyelin/ceramide ratios specifically regulate BACE1 clustering and

What are the specific molecular determinants that govern tau strain selection du

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

Are interneuron oscillation deficits compensatory responses or primary pathologi

What are the precise temporal dynamics of astrocyte ketone production decline du

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

How does engineered C. butyricum cross the blood-brain barrier to directly bind

What are the physiological functions of BACE1 beyond APP processing that could c

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

What specific molecular mechanisms link APOE4 to cholesterol dysregulation in ol

What are the specific circulating factors in exercise-conditioned plasma that me

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

What molecular mechanisms enable functional recovery and muscle re-innervation a

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

What is the molecular mechanism by which oligodendroglial MCT1 disruption causes

What molecular mechanism causes VCP mutations to trigger aberrant HIF-1α activat

How do the seven novel ALS genes function in animal models to cause neurodegener

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

Experiments (0)

Related Papers (0)

Debates (20)

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

What is the role of microglial synaptic pruning in Alzheimer's disease and other

Which proteins are differentially expressed in AD CSF and brain tissue, and do t

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

The debate revealed conflicting evidence about whether TRPML1 activation rescues

The debate framework mentioned multiple microglial subtypes but no analysis was

Is a 12-protein CSF panel superior to existing plasma p-tau217 for clinical AD p

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

test

The abstract explicitly questions whether AD's hallmark pathologies induce choli